| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:538041416:1643 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:538041416:1643?format=raw |
LEADER: 01643fam a2200397 a 4500
001 3976897
005 20221027012635.0
008 930422s1993 nyua b 101 0 eng c
010 $a 93011076
020 $a0781700876
035 $a(OCoLC)28112306
035 $a(OCoLC)ocm28112306
035 $9AHL3956HS
035 $a(NNC)3976897
035 $a3976897
040 $aDNLM/DLC$cDLC$dDLC$dNNC-M
050 00 $aRC531$b.I46 1993
060 00 $aW1 LE886 v.8 1993$aWM 172 I32 1993
082 00 $a616.85/223061$220
245 00 $aImidazopyridines in anxiety disorders :$ba novel experimental and therapeutic approach /$ceditors, Guiseppe Bartholini [and others].
260 $aNew York :$bRaven Press,$c1993.
300 $axv, 256 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aL.E.R.S. monographs series ;$vv. 8
504 $aIncludes bibliographical references and index.
650 0 $aAnxiety$xChemotherapy$vCongresses.
650 0 $aAlpidem$vCongresses.
650 0 $aBenzodiazepines$xReceptors$vCongresses.
650 2 $aAnxiety Disorders$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D001008Q000188
650 2 $aImidazoles$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D007093Q000627
650 2 $aPyridines$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D011725Q000627
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aBartholini, G.$q(Giuseppe)$0http://id.loc.gov/authorities/names/n77002734
830 0 $aL.E.R.S. monograph series ;$vv. 8.$0http://id.loc.gov/authorities/names/n83708053
852 00 $boff,hsl$hRC531$i.I46 1993